<DOC>
	<DOCNO>NCT01561469</DOCNO>
	<brief_summary>The objective study review local management patient methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia treat vancomycin linezolid goal define difference exist among antimicrobial regard clinical economic outcome .</brief_summary>
	<brief_title>Evaluation Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid Vancomycin</brief_title>
	<detailed_description>Non-randomized , retrospective , observational study</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Staphylococcal Infections</mesh_term>
	<mesh_term>Linezolid</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<criteria>Patients enrol study fulfill follow three inclusion criterion : 1 . Protocol criterion HAP/VAP : Criteria make correct diagnosis HAP meet patient develop new progressive pulmonary infiltrate associate least two follow : new increased respiratory symptomatology ( cough , sputum tracheal secretion , shortness breath ) , fever hypothermia , leukocytosis , leave shift , leukopenia , deterioration pulmonary function . 2 . Isolation MRSA respiratory sample blood culture within 48 hour diagnosis HAP/VAP 3 . Treatment MRSA HAP/VAP either vancomycin linezolid incorporation 100 patient vancomycin arm 100 patient linezolid arm Patients meet enrollment criterion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Linezolid</keyword>
	<keyword>Vancomycin</keyword>
	<keyword>Ventilator-Associated Pneumonia</keyword>
	<keyword>Respiratory Tract Infections</keyword>
</DOC>